Our organization includes the core functions and, in addition, strategic planning, operational excellence, and SHE. This enables flexible solutions through well-established decisions. The company is led by the CEO and the executive leadership team and locally by site leadership teams.
Kenneth joined Sever Pharma Solutions as CEO in 2009 and brings 25 years of pharmaceutical industry experience. He has served in several roles at Nordic Group, including SVP of Technical operations and Strategic Development. Prior to this, he spent eight years in several international positions with Xellia pharmaceuticals, incl GM China, and five years in different technical roles with Novo Nordisk. Kenneth holds an MSc in chemical engineering from the technical university of Denmark (DTU) and an executive MBA from HEC in Paris.
Christian joined Sever Pharma Solutions as Group CFO in 2020 and brings more than 15 years of pharmaceutical industry experience. He has served in several roles at Novo Nordisk, including CFO of Novo Nordisk Pharmatech A/S, Finance & Operations Director positions in Novo Nordisk Sweden and Mexico and various management roles in HQ procurement. Prior to this, he was employed at the Confederations of Danish Industries. Christian holds a Ma (Law) from University of Copenhagen and an executive MBA from Scandinavian Management Institute in Copenhagen (SIMI).
Guido joined Sever Pharma Solutions in July 2019 as site Manager for the Dutch site and became VP BD & Commercial in Jan 2021. Guido has a track record in management, sales and marketing positions for over 25 years. All over his career customer focused strategy has been the focus point of his thinking and activities. Creating strong partnerships with customers is on the top of his lists of priorities. He was responsible for the development of a (global) Key Account management program at Organon, became General Manager for Nordic Pharma in the Netherlands and was responsible for BD activities, both in the Netherlands as internationally.
Tony is responsible for the development of new melt extrusion technologies at Sever Pharma Solutions’ Putnam, CT site. Tony is an expert in the areas of polymer materials and polymer processing. He has worked on polymer-based drug delivery systems and dosage forms for more than 15 years. Tony holds both a BS and MS in Plastics Engineering from the University of Massachusetts in Lowell, MA, and an MBA from the University of Massachusetts in Amherst, MA. He holds 2 issued US patents and has authored and/or co-authored 20 publications.
Linda joined Sever Pharma Solutions in April 2020 and have more than 20 years of experience, mainly in the pharmaceutical industry but also in the food ingredient industry. She has held several roles at Polypeptide Laboratories AB such a Development Chemist, Manager of Synthesis Department and Global Process Excellence Manager. Most recently, she worked as Lean Director in Chr. Hansen A/S. Linda holds an MCs in Chemical Engineering from Lund University and has a Black Belt certification in Lean Six Sigma.
Wouter is a seasoned expert in controlled release drug delivery and inventor of more than 15 patents related to controlled release formulations. Before joining Sever Pharma Solutions in 2015 he headed the pharmaceutical development of polymer-based delivery systems within MSD (Merck) and the legacy companies Schering Plough and Organon. At Sever Pharma Solutions he is responsible for Research and Development, including Regulatory Affairs. Wouter graduated from the University of Amsterdam and holds an MSc in chemical engineering.
Jessica joined Sever Pharma Solutions as Global HR Director in August 2022. Jessica has held several international positions in various industries, latest as Chief Human Resources Officer for ROCKWOOL Group. Before that she had a longer career in different roles with ASSA ABLOY, Jysk and Walmart, including heading up all HR operations globally. Besides HR competencies, Jessica brings experience of business leadership and change management. Jessica holds a Bachelor of Science in Human Resource development and Employment Law from Uppsala University in Sweden.
Jakob is General Counsel for Sever Pharma Solutions, heading up the company’s legal affairs and compliance matters. He joined the company in November 2021 and has a broad global corporate legal background with more than 20 years of experience in the life science, industrial, and manufacturing industries. He started his career as a lawyer with major Swedish law firms, then moved to in-house corporate counsel roles. Jakob has served in several roles at Mölnlycke Health Care, including EVP Legal and General Counsel and as General Counsel for Assa Abloy Entrance Systems. Jakob holds a Master of Laws from Lund University and has studied at the School of Business, Economics and Law at the University of Gothenburg.
